Position in GRFS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,841,150
-$4,079,654 QoQ
Shares Held
2,661,180
-6.9% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in GRFS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,841,150 | 2,661,180 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $22,920,804 | 2,857,956 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,134,635 | 3,222,956 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $29,816,402 | 2,993,615 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $17,304,618 | 1,914,228 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $17,454,407 | 2,454,910 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,742,140 | 1,578,245 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $21,811,717 | 2,456,275 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $18,856,492 | 2,988,351 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $12,641,162 | 1,892,390 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $34,554,513 | 2,989,145 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $19,567,502 | 2,140,865 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $17,515,814 | 1,912,207 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,586,275 | 1,843,457 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,537,827 | 1,827,980 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,924,754 | 1,448,824 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $42,907,468 | 3,611,740 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $5,216,811 | 446,645 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $7,639,036 | 680,235 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,570,445 | 1,065,739 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,431,011 | 658,848 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $6,734,159 | 389,483 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,642,339 | 197,524 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,153,396 | 181,752 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $239,347,668 | 13,122,131 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $24,224,874 | 1,202,824 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||